🇺🇸 FDA
Patent

US 7521418

Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent

granted A61KA61K31/7052A61K38/14

Quick answer

US patent 7521418 (Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent) held by Theravance, Inc. expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/7052, A61K38/14, A61K45/06, A61P